Treatment for Lyme Disease
First-Line Oral Antibiotic Regimens
For early Lyme disease in adults and children ≥8 years old, doxycycline 100 mg twice daily for 10-14 days is the preferred first-line treatment, with amoxicillin and cefuroxime axetil as equally effective alternatives. 1, 2
Adult Dosing Options
- Doxycycline: 100 mg orally twice daily for 10-14 days (preferred due to shorter duration and coverage of co-infection with human granulocytic anaplasmosis) 3, 1
- Amoxicillin: 500 mg orally three times daily for 14-21 days 3, 1
- Cefuroxime axetil: 500 mg orally twice daily for 14-21 days 3, 1
All three regimens demonstrate comparable efficacy with complete response rates exceeding 83% at 30 months, with no significant differences in treatment outcomes. 4
Pediatric Dosing Considerations
For children <8 years old, amoxicillin is the preferred first-line agent at 50 mg/kg per day divided into 3 doses (maximum 500 mg per dose) for 14 days. 5
For children ≥8 years old, doxycycline is preferred at 4 mg/kg per day in 2 divided doses (maximum 100 mg per dose) for 14 days. 3, 5
Cefuroxime axetil is an alternative for children <8 years at 30 mg/kg per day in 2 divided doses for 14 days. 5
Recent evidence suggests doxycycline is safe and effective in children <8 years old for courses up to 3 weeks, though amoxicillin remains the preferred agent for this age group. 6, 7
Treatment Duration
Do not extend treatment beyond 21 days for early Lyme disease, as longer courses provide no additional benefit. 1, 4
- Doxycycline requires only 10 days of therapy due to its longer half-life 1, 2
- Beta-lactam antibiotics (amoxicillin, cefuroxime axetil) require a full 14-day course due to shorter half-lives 5
- Extending treatment from 10 to 20 days showed no improvement in efficacy (83.9% vs 90.3% complete response, P > 0.2) 4
Important Administration Guidelines
Doxycycline must be taken with 8 ounces of fluid to reduce esophageal irritation and with food to minimize gastrointestinal side effects. 1, 5
Patients taking doxycycline must avoid sun exposure due to photosensitivity risk. 1, 5
Doxycycline is contraindicated in pregnant or lactating women. 1
Second-Line Options (Use Only When First-Line Agents Cannot Be Tolerated)
Macrolide antibiotics are significantly less effective than first-line agents and should only be used when patients are intolerant of doxycycline, amoxicillin, AND cefuroxime axetil. 3, 1
Adult macrolide dosing (if absolutely necessary):
- Azithromycin: 500 mg orally daily for 7-10 days 3
- Clarithromycin: 500 mg orally twice daily for 14-21 days (not in pregnancy) 3
- Erythromycin: 500 mg orally four times daily for 14-21 days 3
Patients treated with macrolides require close observation to ensure clinical resolution. 3
Critical Pitfalls to Avoid
Never use first-generation cephalosporins (e.g., cephalexin) as they are completely inactive against Borrelia burgdorferi. 1, 5, 2
Do not prescribe fluoroquinolones or carbapenems, as they are not recommended for Lyme disease. 5
Avoid long-term antibiotic therapy beyond 21 days, which lacks supporting evidence and may cause harm. 5
Treatment failure is extremely rare (<10%) with appropriate antibiotic therapy, and objective evidence of treatment failure occurred in only 1 of 180 patients in a major randomized trial. 4
Special Clinical Scenarios
For neurological involvement (meningitis, radiculopathy), parenteral therapy with ceftriaxone 50-75 mg/kg per day (maximum 2g) is required. 5
For isolated facial nerve palsy without other neurological signs and normal cerebrospinal fluid, oral therapy is usually sufficient. 8
Patients with acute disseminated Lyme disease (multiple erythema migrans lesions) without meningitis can be treated with oral doxycycline rather than parenteral ceftriaxone, as both show equal efficacy (85% vs 88% cure rates). 9
Monitoring and Expected Outcomes
Most patients respond promptly and completely to appropriate antibiotic therapy. 5, 2
Patients should be monitored for 30 days after tick removal for development of erythema migrans or systemic symptoms. 3
Mild Jarisch-Herxheimer-like reactions may occur within the first 24 hours of treatment but are typically transient. 2
Residual symptoms (such as mild arthralgia) may persist in 14-27% of successfully treated patients but do not indicate treatment failure or need for additional antibiotics. 9